(Q46699870)

24 December 2017

title

Effects of zotepine and olanzapine on noradrenaline transporter in cultured bovine adrenal medullary cells (English)

1 reference

24 December 2017

1 reference

1

Reiji Yoshimura

1 reference

24 December 2017

Jun Nakamura

6

Jun Nakamura

1 reference

24 December 2017

Koji Shinkai

2

Koji Shinkai

1 reference

24 December 2017

Yumiko Toyohira

3

Yumiko Toyohira

1 reference

24 December 2017

Nobuyuki Yanagihara

5

Nobuyuki Yanagihara

1 reference

24 December 2017

author name string

Susumu Ueno

4

1 reference

24 December 2017

publication date

1 October 2005

1 reference

24 December 2017

published in

Human Psychopharmacology

1 reference

24 December 2017

volume

20

1 reference

24 December 2017

issue

7

1 reference

24 December 2017

page(s)

477-484

1 reference

24 December 2017

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

cites work

1 reference

Clozapine--pharmacokinetic investigations and biochemical effects in man.

21 January 2018

1 reference

7 January 2021

Zotepine in the treatment of schizophrenic patients with prevailingly negative symptoms. A double-blind trial vs. haloperidol

1 reference

7 January 2021

Determinants within the C-terminus of the human norepinephrine transporter dictate transporter trafficking, stability, and activity

1 reference

7 January 2021

The noradrenaline transporter of the neuronal plasma membrane

1 reference

7 January 2021

Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium

1 reference

7 January 2021

Dual effects of intravenous anesthetics on the function of norepinephrine transporters.

1 reference

7 January 2021

Double-blind comparison of 3 x 75 mg zotepine und 3 x 4 mg haloperidol in acute schizophrenic patients

1 reference

7 January 2021

Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum

1 reference

7 January 2021

Cloning and expression of the bovine sodium- and chloride-dependent noradrenaline transporter

1 reference

7 January 2021

Clinical outcome and olanzapine plasma levels in acute schizophrenia

1 reference

7 January 2021

Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter

1 reference

7 January 2021

Olanzapine plasma concentrations and clinical response in acutely ill schizophrenic patients

1 reference

7 January 2021

1 reference

7 January 2021

Functional significance of a highly conserved glutamate residue of the human noradrenaline transporter

1 reference

7 January 2021

Antipsychotic drugs induce similar effects on the release of dopamine and noradrenaline in the medial prefrontal cortex of the rat brain

1 reference

7 January 2021

Stimulatory effect of IL-1 beta on catecholamine secretion from cultured bovine adrenal medullary cells

1 reference

7 January 2021

Phosphorylation of chromogranin A and catecholamine secretion stimulated by elevation of intracellular Ca2+ in cultured bovine adrenal medullary cells

1 reference

7 January 2021

Inhibitory effects of clozapine and other antipsychotic drugs on noradrenaline transporter in cultured bovine adrenal medullary cells.

1 reference

7 January 2021

Effect of risperidone on plasma free 3-methoxy-4-hydroxyphenylglycol (pMHPG) levels in schizophrenic patients: relationship among plasma concentrations of risperidone and 9-hydroxyrisperidone, pMHPG levels, and clinical improvement

1 reference

7 January 2021

Dual phases of functional change in norepinephrine transporter in cultured bovine adrenal medullary cells by long-term treatment with clozapine

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.715

1 reference

24 December 2017

1 reference

24 December 2017